INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

78,999 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
SG
Simmonds Sidney GDirector
FVCBFVCBankcorp, Inc.
Option exercise
M$198K
21.5K sh
Apr 17, 2026Apr 20, 2026
Page 1154 of 1975
← PrevNext →
traded Apr 17, 2026
+3d
SEC Form 4

Evidence

12
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
24.0K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
25.3K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
CS
Chen ShipingDirector, Chief Operating Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
12.2K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

11
AL
Azar Samak LChief Legal Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$24K
500 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

10
SS
Subramanian SrinivasExecutive Vice President
NDSNNORDSON CORP
Option exercise · 10b5-1 plan
M$205K
1,900 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

10
LH
Litinsky James H.Director, Chairman and CEO
MPMP Materials Corp. / DE
Open-market sale · 10b5-1 plan
SELL$16.60M
259.2K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
MS
Mccollam SharonPresident & CFO
ACIAlbertsons Companies, Inc.
Grant or award
A—
128.3K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
VL
Valdez Gloria LDirector
ESEESCO TECHNOLOGIES INC
Grant or award
A$675
2 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

9
BS
Bhutani Amanpal SinghDirector
NYTNEW YORK TIMES CO
Grant or award
A—
81 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CS
Chen ShipingDirector, Chief Operating Officer
ALMRAlamar Biosciences, Inc.
Grant or award
A—
163.4K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,465 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
RE
Rainwater EvanEVP, Supp. Chain, Mfg. & Sourc
ACIAlbertsons Companies, Inc.
Grant or award
A—
17.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
606 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
6,250 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
BR
Backus RobertEVP Retail Operations East
ACIAlbertsons Companies, Inc.
Grant or award
A—
15.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
1,120 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
4.59M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
BA
Brooke Beth A.Director
NYTNEW YORK TIMES CO
Grant or award
A—
54 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Grant or award
A—
5,686 sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
1,191 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
271.8K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
2.09M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,133 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
LM
Larson MichelleChief Merchandising Officer
ACIAlbertsons Companies, Inc.
Grant or award
A—
106.9K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
1,322 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
WM
Withers MichaelEVP Retail Operations West
ACIAlbertsons Companies, Inc.
Grant or award
A—
15.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M—
730 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
LB
Larson Robert BruceSVP & Chief Accounting Officer
ACIAlbertsons Companies, Inc.
Grant or award
A—
7,636 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
DA
Dhanda AnujChief Tech &Transformation Off
ACIAlbertsons Companies, Inc.
Grant or award
A—
88.6K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CM
Conner Penelope MDirector
ESEESCO TECHNOLOGIES INC
Grant or award
A$61.76
0 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

9
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,520 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
WO
White Timothy OgdenPresident
ALMRAlamar Biosciences, Inc.
Grant or award
A—
163.4K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,520 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CS
Chen ShipingDirector, Chief Operating Officer
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
176.2K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
4,042 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M—
360 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
2.86M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
2,001 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
587 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence